AstraZeneca has decided to halt its £200 million investment plan at its research center in Cambridge, a project that would have created approximately 1,000 jobs. This is the company's second major withdrawal from the UK in 2024, after it abandoned a £450 million investment in vaccine manufacturing in January. The decisions of pharmaceutical companies, including Merck & Co., are putting pressure on the British government in the context of maintaining attractiveness for investments in the pharmaceutical sector.
Sources
AstraZeneca suspendă o investiţie de 270 de milioane de dolari în Marea Britanie
Britain’s biggest company AstraZeneca pauses £200m investment into Cambridge site
AstraZeneca pauses £200m Cambridge investment
Britain’s biggest company AstraZeneca pauses £200m investment into Cambridge site
Latest News
20:15
Timișoara Airport will resume flights on November 22, after runway works are completed
20:09
Mirabela Grădinaru, at the Warsaw summit on child safety: Protecting children online without limiting their access to the benefits of technology
19:59
The police officers and prosecutors in Giurgiu seized assets in a tax evasion case involving damages of 9 million lei
19:48
Dominic Fritz accuses the PSD of controlling the Government's decisions through Marian Neacșu
19:23
Anthropic debuted on Nasdaq at $111.50 per share and became the most valuable company listed through a public offering
See more news